Hypertrophic Cardiomyopathy Learning Series: Risk Stratification in Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy Learning Series: Risk Stratification in Hypertrophic Cardiomyopathy is organized by Canadian Cardiovascular Society (CCS) and will be held from Jan 02, 2023 - Nov 30, 2025.

Available Until: November 2025

Program description:
This is the second session of the Hypertrophic Cardiomyopathy Learning Series – an educational series consisting of three MOC Section 1 accredited live sessions and three MOC Section 3 accredited programs focusing on HCM.

Learning Objectives:
CanMEDS roles relevant to this activity: Medical Expert, Communicator, Collaborator, Leader, Scholar

Overall Learning Objectives (Medical expert, Communicator, Collaborator, Leader, Scholar)
• Discuss stratification approach to identify the risk of sudden death in hypertrophic cardiomyopathy.
• Understand how diagnostic tools contribute to the prediction of the risk of sudden death in hypertrophic cardiomyopathy.
• Review current evidence to refine the decision-making process regarding device intervention in hypertrophic cardiomyopathy .

Individual Learning Objectives
Case Presentation
• Discuss a risk stratification approach for sudden cardiac death in a patient with hypertrophic cardiomyopathy (Medical Expert, Communicator, Collaborator)

U/S Waves Speak Volumes: Risk Stratification for HCM From an Echocardiography Viewpoint (Medical Expert, Communicator, Collaborator)
• Recognize echocardiographic features of hypertrophic cardiomyopathy that are associated with an increased risk of sudden cardiac death
• Identify the strengths of echocardiography and situations when additional advanced imaging is needed

Protons for Prognosis: Risk Stratification for HCM From an MRI Viewpoint (Medical Expert, Communicator, Collaborator, Scholar)
• Understand and apply cardiac magnetic resonance imaging as a prognostication tool for patients with hypertrophic cardiomyopathy
• Understand especially the fundamentals of late gadolinium enhancement imaging and its role for risk prediction in hypertrophic cardiomyopathy

Beyond the Pictures: Who, What, When and How? (Medical Expert, Communicator, Collaborator, Leader)
• Develop comprehensive approach to decision making regarding primary prevention ICDs in hypertrophic cardiomyopathy
• Discuss options and evidence for device intervention.

Additional details will be posted as soon as information is available.